|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 134.49 USD | +0.19% |
|
+0.14% | +78.18% |
| 08-04 | AbbVie Launches $10 Billion Bond Sale to Fund Apogee Acquisition, Bloomberg Reports | MT |
| 08-04 | AbbVie Launches $10 Billion Bond Sale to Fund Apogee Acquisition | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 135.01 | 182.8 | 226.42 |
| Spread/Res. | -0.38% | -26.43% | -40.60% |
| Spread/Supp. | +0.71% | +47.95% | +96.54% |
| Support | 133.54 | 90.9 | 68.43 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- APGE Stock
- Charts Apogee Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
